Daiken Biomedical Co (TPE:7780) Interest Coverage: 264.58 (As of Dec. 2025) — 240% Above Median


TPE:7780 Daiken Biomedical Co Ltd TPE:7780
23 GF Score
Price NT$18.35
! 6 Warning Signs
View Full Analysis

What is Daiken Biomedical Co Interest Coverage?

Daiken Biomedical Co TPE:7780 +1.66% 23 Interest Coverage is 264.58 as of Dec. 2025, which is 240% above its 10-year median of 77.84. GuruFocus rates TPE:7780 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review. Among 1,504 Consumer Packaged Goods companies, Daiken Biomedical Co ranks better than 91.89% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Daiken Biomedical Co's Operating Income for the three months ended in Dec. 2025 was NT$124 Mil. Daiken Biomedical Co's Interest Expense for the three months ended in Dec. 2025 was NT$-0 Mil. Daiken Biomedical Co's interest coverage for the quarter that ended in Dec. 2025 was 264.58. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Daiken Biomedical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Daiken Biomedical Co's Interest Coverage or its related term are showing as below:

TPE:7780' s Interest Coverage Range Over the Past 10 Years
Min: 24.95   Med: 77.84   Max: 484.43
Current: 484.43


TPE:7780's Interest Coverage is ranked better than
91.89% of 1504 companies
in the Consumer Packaged Goods industry
Industry Median: 8.585 vs TPE:7780: 484.43

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Daiken Biomedical Co  (TPE:7780) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Daiken Biomedical Co Interest Coverage Related Terms


Daiken Biomedical Co Interest Coverage Historical Data

* Premium members only.

The historical data trend for Daiken Biomedical Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Daiken Biomedical Co Interest Coverage Chart

Daiken Biomedical Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Interest Coverage
94.97 60.71 24.95 484.43

Daiken Biomedical Co Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 108.06 2,628.07 8,932.60 768.10 264.58

TPE:7780 vs KHC, GIS: Interest Coverage Comparison

For the Packaged Foods subindustry, Daiken Biomedical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiken Biomedical Co Interest Coverage vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Daiken Biomedical Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Daiken Biomedical Co's Interest Coverage falls into.


TPE:7780
23GF Score
Daiken Biomedical Co Ltd TPE:7780
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiken Biomedical Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Daiken Biomedical Co's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Daiken Biomedical Co's Interest Expense was NT$-1 Mil. Its Operating Income was NT$288 Mil. And its Long-Term Debt & Capital Lease Obligation was NT$15 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2025 )/Interest Expense (A: Dec. 2025 )
=-1*288.235/-0.595
=484.43

Daiken Biomedical Co's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Here, for the three months ended in Dec. 2025, Daiken Biomedical Co's Interest Expense was NT$-0 Mil. Its Operating Income was NT$124 Mil. And its Long-Term Debt & Capital Lease Obligation was NT$15 Mil.

Interest Coverage=-1* Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*123.824/-0.468
=264.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 264.58 mean?
Daiken Biomedical Co (TPE:7780) has a Interest Coverage of 264.58 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Daiken Biomedical Co and its competitors. This is 240% above median its historical median of 77.84. Over the past decade, Daiken Biomedical Co's Interest Coverage has ranged from 24.95 to 484.43. According to the industry distribution chart, Daiken Biomedical Co ranks #122 out of 1504 companies in the Consumer Packaged Goods industry, placing it in the top 8.1%.
Is Daiken Biomedical Co's Interest Coverage too high?
Daiken Biomedical Co's current Interest Coverage of 264.58 is 240% above median its 10-year median of 77.84. Over the past 10 years, this metric has ranged from a low of 24.95 to a high of 484.43. The Consumer Packaged Goods industry median Interest Coverage is 8.59. Daiken Biomedical Co's value of 264.58 is 2981.9% above this industry median. Based on the distribution chart, Daiken Biomedical Co ranks #122 out of 1504 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Daiken Biomedical Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Daiken Biomedical Co's Interest Coverage compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Daiken Biomedical Co ranks #122 out of 1504 companies for Interest Coverage. This places Daiken Biomedical Co in the top 8% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 8.59. Daiken Biomedical Co's value of 264.58 is 2981.9% above this benchmark. Historically, Daiken Biomedical Co's own Interest Coverage has ranged from 24.95 to 484.43 over the past decade. While the company's 10-year median is 77.84 vs. the industry median of 8.59, Daiken Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Consumer Packaged Goods company?
The median Interest Coverage among Consumer Packaged Goods companies is 8.59, based on 1,504 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiken Biomedical Co's current Interest Coverage of 264.58 is 2981.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Daiken Biomedical Co and its competitors. For the Consumer Packaged Goods industry, the median Interest Coverage is 8.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiken Biomedical Co's current Interest Coverage is 264.58, which is 240% above median its own 10-year median of 77.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Biomedical Co stock overvalued right now?
Daiken Biomedical Co (TPE:7780) has a current Interest Coverage of 264.58. The current Interest Coverage is 264.58, which is 240% above median its 10-year median of 77.84 and 2981.9% above the Consumer Packaged Goods industry median of 8.59. Daiken Biomedical Co's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Daiken Biomedical Co (TPE:7780), the current Interest Coverage is 264.58 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Daiken Biomedical Co Business Description

Address Roosevelt Road, 12th Floor, No. 37, Section 3, Daan District, Taipei, TWN
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules. The companies reportable operating segment consists solely of the e-commerce division.
23GF Score

Get the complete analysis for TPE:7780

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.35
Price